{{Rsnum
|rsid=3785152
|Gene=SLC6A2
|Chromosome=16
|position=55682638
|Orientation=plus
|GMAF=0.1249
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=SLC6A2
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 85.8 | 13.3 | 0.9
| HCB | 70.8 | 27.0 | 2.2
| JPT | 85.0 | 14.2 | 0.9
| YRI | 58.5 | 36.7 | 4.8
| ASW | 63.2 | 35.1 | 1.8
| CHB | 70.8 | 27.0 | 2.2
| CHD | 67.9 | 31.2 | 0.9
| GIH | 83.2 | 16.8 | 0.0
| LWK | 61.8 | 33.6 | 4.5
| MEX | 81.0 | 15.5 | 3.4
| MKK | 73.7 | 21.8 | 4.5
| TSI | 85.3 | 14.7 | 0.0
| HapMapRevision=28
}}T allele associated with better response to treatment of [[ADHD]] with [[atomoxetine]]. {{PMID|19387424}}

{{PMID Auto
|PMID=18937309
|Title=Sexually dimorphic effects of four genes (COMT, SLC6A2, MAOA, SLC6A4) in genetic associations of ADHD: a preliminary study.
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}